Advances in SARS-CoV-2 S protein-induced inflammatory response of respiratory epithelial cells
Author:
Affiliation:

1.Department of Physiology, School of Basic Medicine, Guangdong Medical University, Zhanjiang 524023, China;2.Department of Biology, School of Basic Medicine, Guangdong Medical University, Zhanjiang 524023, China

Clc Number:

+2  R511]]>

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Comments
    Abstract:

    Pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection poses a threat to human life and health, resulting in great socio-economic losses. The structural protein spike protein (S protein) of viruses has always been considered to primarily mediate virus invasion into host cells. S protein can act independently of viruses and cause inflammatory reactions on a variety of cells, therefore, understanding the impact of S protein on the respiratory tract can provide a new perspective for the prevention and treatment of COVID -19. This article reviews the advances in the possible mechanisms and clinical manifestations of SARS-CoV-2 structural protein S protein-induced inflammatory response in respiratory epithelial cells, aiming to provide reference for the prevention and treatment of diseases.

    Reference
    Related
Get Citation

刘兴健,张华华,张锐钢. SARS-CoV-2 S蛋白引起呼吸道上皮细胞炎症反应的研究进展[J].中国感染控制杂志英文版,2024,23(1):112-118. DOI:10.12138/j. issn.1671-9638.20244581.
Xing-jian LIU, Hua-hua ZHAGN, Rui-gang ZHANG. Advances in SARS-CoV-2 S protein-induced inflammatory response of respiratory epithelial cells[J]. Chin J Infect Control, 2024,23(1):112-118. DOI:10.12138/j. issn.1671-9638.20244581.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:June 08,2023
  • Revised:
  • Adopted:
  • Online: April 28,2024
  • Published: